LAVA THERAPEUTICS NV (LVTX)

NL0015000AG6 - Common Stock

3.1  +0.13 (+4.38%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
6.77M19.39M5.00M3.50M0.00
Cost Of Goods
3.48MN/AN/AN/AN/A
Gross Profit
3.29MN/AN/AN/AN/A
Operating Expenses
46.54M54.23M49.35M18.42M9.58M
Research and Development
33.81M40.11M37.19M15.70M8.35M
Selling, General, and Administrative Expenses
12.73M14.12M12.16M2.72M1.24M
Operating Income
-43.25M-34.84M-44.35M-14.92M-9.58M
Interest Income/Expense
1.56M3.18M-840.00K-540.00K-100.00K
Income Before Taxes
-41.70M-31.66M-45.19M-15.46M-9.69M
Income Tax
279.00K250.00K160.00K40.00K0.00
Net Income
-41.97M-31.91M-45.35M-15.51M-9.69M
EBITDA
-41.98M-34.06M-43.79M-14.46M-9.32M
 
Per Share Data
EPS Diluted Total Ops
-1.57-1.23-2.30-0.61-0.38
Non GAAP EPS
-1.59-1.25-11.12N/AN/A
 
Statistics
Gross Profit Margin
48.56%N/AN/AN/AN/A
Profit Margin
-620.09%-164.57%-907.00%-443.14%N/A
Operating Profit Margin
-638.99%-179.68%-887.00%-426.29%N/A

All data in USD

Charts